中文

振东制药 Revenue Breakdown

Period 2026-03-31 ・ Reported 2026-04-21
ItemAmountY/Y
Revenue¥0.65B-14.0%
Gross profit¥0.35B
Operating income¥0.00B
Net income¥-0.00B-218.2%
Gross margin53.7%Net margin -0.2%
Revenue Q/Q+14.2%

Revenue Segments

The filing did not disclose a revenue breakdown for this period.

Costs & Expenses

ItemAmount% of revenue
Cost of revenue¥0.30B46.3%
R&D¥0.05B7.0%
SG&A¥0.30B46.8%
Tax & other¥0.01B0.8%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

新研股份秀强股份华中数控雷曼光电先锋新材通源石油天瑞仪器东方国信ST迪威迅万达信息天晟新材汉得信息

Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies